Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.15p
   
  • Change Today:
      0.008p
  • 52 Week High: 1.01p
  • 52 Week Low: 0.12p
  • Currency: UK Pounds
  • Shares Issued: 2,295.93m
  • Volume: 9,608,088
  • Market Cap: £3.50m
  • Beta: 0.02

SVNS Overview

Our motto “COMBINE INCOMPATIBLE” defines the essence of our business which is to create polymer modifiers & alloys which combine immiscible and incompatible components of polymers to achieve a versatile range of mechanical characteristics including good impact and chemical resistance, fire retardant properties and cost-effectiveness.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.1  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SVNS Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 0.52 (0.45) (0.65)p n/a n/a n/a n/a 0.0%
31-Dec-21 0.22 (0.95) (1.36)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.54 (2.70) (2.61)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.59 (3.12) (3.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (1.45) (0.12)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SVNS Company Announcements

Proposed acquisition of Awakn approved 23-Apr-2025 07:00 RNS
Final Results for the year ended 31 December 2024 16-Apr-2025 07:00 RNS
Posting of Circular and Notice of General Meeting 10-Apr-2025 14:00 RNS

SVNS ShareCast News

Graft Polymer to buy Awakn in £4.98m deal 16-Dec-2024 ShareCast

Latest SVNS Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.15p
Change Today 0.008p
% Change 5.17 %
52 Week High 1.01p
52 Week Low 0.12p
Volume 9,608,088
Shares Issued 2,295.93m
Market Cap £3.50m
Beta 0.02

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.27% below the market average2.27% below the market average2.27% below the market average2.27% below the market average2.27% below the market average
78.72% above the sector average78.72% above the sector average78.72% above the sector average78.72% above the sector average78.72% above the sector average
Price Trend
7.47% above the market average7.47% above the market average7.47% above the market average7.47% above the market average7.47% above the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 25-Apr-2025

Time Volume / Share Price
11:07 1,135,995 @ 0.15p
10:51 154,142 @ 0.15p
09:04 186,487 @ 0.16p
09:02 7,000 @ 0.15p
09:02 1,400 @ 0.15p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page